UCB Stock Analysis: United Community Banks | NYSE
Banks - Regional | NYSE, USA | Market Cap: 4.461m USD | 12M Return: 23.5% | US90984P3038 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 33.6M
EPS Trend: 98.3%
Qual. Beats: 0
Rev. Trend: 38.4%
Qual. Beats: -1
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
United Community Banks, Inc. (NYSE: UCB) is the bank holding company for United Community Bank, a U.S.-based regional financial institution founded in 1950 and headquartered in Greenville, South Carolina. The company provides a broad range of banking services, including deposit products (checking, savings, and money market accounts) and a diversified loan portfolio spanning commercial real estate, commercial and industrial, equipment financing, residential mortgage, home equity, manufactured housing, consumer loans, and construction and land development. Its loan book reflects a mix of both owner-occupied and income-producing CRE, illustrating a traditional community-bank balance sheet structure typical of regional banking franchises.
Beyond core lending and deposit-taking, United Community offers wealth management, private banking, trust, estate and retirement planning, investment advisory, and insurance products-including life insurance, long-term care coverage, and tax-deferred annuities. It also engages in reinsurance of property insurance contracts and provides payment processing services to commercial and small business clients. The company serves a diverse customer base across the commercial, retail, government, education, energy, health care, and real estate sectors, underscoring the diversified revenue streams common to mid-sized regional banks. As a mid-cap financial institution listed since 2002, UCB operates within the regional banking sub-industry, where net interest margin, loan portfolio mix, and fee-based services are typically key performance drivers.
- Net interest margin compresses as Fed cuts rates
- CRE loan portfolio exposure raises credit quality concerns
- Southeast deposit growth fuels loan portfolio expansion
| Net Income: 146.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.01 > 1.0 |
| NWC/Revenue: -1.38k% < 20% (prev -1.29k%; Δ -89.95% < -1%) |
| CFO/TA 0.02 > 3% & CFO 487.6m > Net Income 146.6m |
| Net Debt (-7.38b) to EBITDA (250.2m): -29.51 < 3 |
| Current Ratio: 0.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (120.5m) vs 12m ago -1.47% < -2% |
| Gross Margin: 66.03% > 18% (prev 63.88%; Δ 2.15% > 0.5%) |
| Asset Turnover: 4.43% > 50% (prev 5.38%; Δ -0.95% > 0%) |
| Interest Coverage Ratio: 0.41 > 6 (EBIT TTM 175.2m / Interest Expense TTM 424.5m) |
| A: -0.60 (Total Current Assets 7.46b - Total Current Liabilities 24.9b) / Total Assets 28.9b |
| B: 0.03 (Retained Earnings 882.0m / Total Assets 28.9b) |
| C: 0.01 (EBIT TTM 175.2m / Avg Total Assets 28.5b) |
| D: 0.14 (Book Value of Equity 3.51b / Total Liabilities 25.4b) |
| Altman-Z'' = -3.67 = D |
As of November 20, 2026, the stock is trading at USD 35.64 with a total of 765,155 shares traded. Over the past week, the price has changed by -4.37%, over one month by +5.51%, over three months by +0.43% and over the past year by +23.45%.
Current recommended Stop Loss: 34.00 (which is 4.6% or 2.2 ATR below the current price).
United Community Banks has received a consensus analysts rating of 3.71. Therefore, it is recommended to hold UCB.
- StrongBuy: 2
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 40.9 | 14.7% |
P/E Trailing = 31.3445
P/E Forward = 12.5313
P/S = 5.4568
P/B = 1.2726
P/EG = 1.674
Revenue TTM = 1.26b USD
EBIT TTM = 175.2m USD
EBITDA TTM = 250.2m USD
Long Term Debt = 39.7m USD (from longTermDebt, last quarter)
Short Term Debt = 85.0m USD (from shortTermDebt, last fiscal year)
Debt = 39.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -7.38b USD (calculated: Debt 39.7m - CCE 7.42b)
Enterprise Value = 4.46b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.41 (Ebit TTM 175.2m / Interest Expense TTM 424.5m)
EV/FCF = 9.80x (Enterprise Value 4.46b / FCF TTM 455.1m)
FCF Yield = 10.20% (FCF TTM 455.1m / Enterprise Value 4.46b)
FCF Margin = 36.02% (FCF TTM 455.1m / Revenue TTM 1.26b)
Net Margin = 11.61% (Net Income TTM 146.6m / Revenue TTM 1.26b)
Gross Margin = 66.03% ((Revenue TTM 1.26b - Cost of Revenue TTM 429.2m) / Revenue TTM)
Gross Margin QoQ = -22.11% (prev 80.75%)
Tobins Q-Ratio = 0.15 (Enterprise Value 4.46b / Total Assets 28.9b)
Interest Expense / Debt = 1.07k% (Interest Expense 424.5m / Debt 39.7m)
Taxrate = 21.15% (39.3m / 186.0m)
NOPAT = 138.1m (EBIT 175.2m * (1 - 21.15%))
Current Ratio = 0.30 (Total Current Assets 7.46b / Total Current Liabilities 24.9b)
Debt / Equity = 0.01 (Debt 39.7m / totalStockholderEquity, last quarter 3.51b)
Debt / EBITDA = -29.51 (Net Debt -7.38b / EBITDA 250.2m)
Debt / FCF = -16.22 (Net Debt -7.38b / FCF TTM 455.1m)
Total Stockholder Equity = 3.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.51% (Net Income 146.6m / Total Assets 28.9b)
RoE = 4.03% (Net Income TTM 146.6m / Total Stockholder Equity 3.64b)
RoCE = 4.76% (EBIT 175.2m / Capital Employed (Equity 3.64b + L.T.Debt 39.7m))
RoIC = 3.44% (NOPAT 138.1m / Invested Capital 4.02b)
WACC = 8.15% (E(4.46b)/V(4.50b) * Re(8.22%) + (debt cost/tax rate unavailable))
Discount Rate = 8.22% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 40.92 | Cagr: 0.25%
[DCF] Terminal Value 75.90% ; FCFF base≈448.8m ; Y1≈464.0m ; Y5≈521.3m
[DCF] Fair Price = 129.1 (EV 8.06b - Net Debt -7.38b = Equity 15.4b / Shares 119.6m; r=8.35% [WACC [floored]]; 5y FCF grow 3.59% → 2.50% )
EPS Correlation: 98.27 | EPS CAGR: 14.99% | SUE: 0.0 | # QB: 0
Revenue Correlation: 38.44 | Revenue CAGR: 3.00% | SUE: -1.03 | # QB: -1
EPS current Quarter (2027-03-31): EPS=0.80 | Chg30d=+3.50% | Revisions=+62% | Analysts=7
EPS current Year (2026-12-31): EPS=3.02 | Chg30d=+0.97% | Revisions=+50% | GrowthEPS=+11.6% | GrowthRev=+6.3%
EPS next Year (2027-12-31): EPS=3.45 | Chg30d=+2.85% | Revisions=+67% | GrowthEPS=+14.2% | GrowthRev=+5.7%
[Analyst] Revisions Ratio: +82% (up=14, down=0)